Charles Lawrence Loprinzi, MD

  • 26942 Citations
  • 84 Scopus h-Index
1982 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Charles Lawrence Loprinzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Hot Flashes Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Placebos Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Peripheral Nervous System Diseases Medicine & Life Sciences
Megestrol Acetate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1983 2015

Survival Rate
Research Personnel
Organized Financing
Skin Neoplasms
Ornithine Decarboxylase
Tetradecanoylphorbol Acetate


Loprinzi, C. L., Moertel, C. G., O'Connell, M., Moertel, C. G. & Moertel, C. G.

National Institutes of Health


Project: Research project

Medical Oncology
Quality Control

Research Output 1982 2020

Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

Loprinzi, C. L., Lustberg, M. B., Hershman, D. L. & Ruddy, K. J., Jan 2020, In : Annals of Oncology. 31, 1, p. 5-6 2 p.

Research output: Contribution to journalEditorial

Open Access

Neuronal Protection for Chemotherapy Neuropathy Prevention?

Loprinzi, C. L., Hershman, D. L. & Staff, N., Jan 1 2020, In : Journal of the National Cancer Institute. 112, 1, p. 3-4 2 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)

A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Smith, T. J., Razzak, A. R., Blackford, A. L., Ensminger, J., Saiki, C., Longo-Schoberlein, D. & Loprinzi, C. L., Jan 1 2019, In : Journal of Palliative Care.

Research output: Contribution to journalArticle

Peripheral Nervous System Diseases
Randomized Controlled Trials
Drug Therapy
8 Citations (Scopus)

Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial

McBane, R. D., Wysokinski, W. E., Le-Rademacher, J. G., Zemla, T., Ashrani, A., Tafur, A., Perepu, U., Anderson, D., Gundabolu, K., Kuzma, C., Perez Botero, J., Leon Ferre, R. A., Henkin, S., Lenz, C. J., Houghton, D. E., Vishnu, P. & Loprinzi, C. L., Jan 1 2019, (Accepted/In press) In : Journal of Thrombosis and Haemostasis.

Research output: Contribution to journalArticle

Venous Thromboembolism
1 Citation (Scopus)

Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview

Chan, A., Hertz, D. L., Morales, M., Adams, E. J., Gordon, S., Tan, C. J., Staff, N. P., Kamath, J., Oh, J., Shinde, S., Pon, D., Dixit, N., D’Olimpio, J., Dumitrescu, C., Gobbo, M., Kober, K., Mayo, S., Pang, L., Subbiah, I., Beutler, A. S. & 3 others, Peters, K. B., Loprinzi, C. L. & Lustberg, M. B., Jan 1 2019, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalReview article

Peripheral Nervous System Diseases
Drug Therapy
Pharmaceutical Preparations
Vinca Alkaloids